Loading...
Combining the best of two worlds: highly flexible chimeric antigen receptor adaptor molecules (CAR-adaptors) for the recruitment of chimeric antigen receptor T cells
Chimeric antigen receptor (CAR)-engineered T cells have a proven efficacy for the treatment of refractory hematological B cell malignancies. While often accompanied by side effects, CAR-T technology is getting more mature and will become an important treatment option for various tumor indications. I...
Saved in:
| Published in: | MAbs |
|---|---|
| Main Authors: | , , , |
| Format: | Artigo |
| Language: | Inglês |
| Published: |
Taylor & Francis
2019
|
| Subjects: | |
| Online Access: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6601549/ https://ncbi.nlm.nih.gov/pubmed/30892136 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1080/19420862.2019.1596511 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|